With the successful production of effective vaccines, it is possible to protect the population from the coronavirus, however, there was skepticism about the safety of vaccinating pregnant women, as they were not included in clinical trials.
Thus, a study involving 17.525 pregnant and lactating women showed that SARS-CoV-2 vaccines are well tolerated in this susceptible population.
61.9% were vaccinated with the Pfizer mRNA vaccine and 37.8% with the Moderna vaccine, while 89.9% of women received both doses. 97% reported any action after the first dose, with more frequent pain at the injection site (91.4%) and fatigue more often (31.3%).
The frequency of reactions was higher with the second dose, but in total only 100 people (0.6%) sought medical help after the first dose, including 50 pregnant women, and 221 women (1.3%) after the second dose. including 156 pregnant women.
More studies are being done to investigate the effects of COVID-19 vaccines in this vulnerable population to ensure their safety, but the results of this study are encouraging.